Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529

Clinical trial NCT01342952 · COMPLETED

Trial details

NCT number: NCT01342952
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension, Pulmonary

Start date: 2011-06-21
Primary completion: 2022-06-09
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.